Cargando…
Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
A primary objective in malaria vaccine design is the generation of high-quality antibody responses against the circumsporozoite protein of the malaria parasite, Plasmodium falciparum (PfCSP). To enable rational antigen design, we solved a cryo-EM structure of the highly potent anti-PfCSP antibody L9...
Autores principales: | Martin, Gregory M., Fernández-Quintero, Monica L., Lee, Wen-Hsin, Pholcharee, Tossapol, Eshun-Wilson, Lisa, Liedl, Klaus R., Pancera, Marie, Seder, Robert A., Wilson, Ian A., Ward, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192352/ https://www.ncbi.nlm.nih.gov/pubmed/37198165 http://dx.doi.org/10.1038/s41467-023-38509-2 |
Ejemplares similares
-
Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection
por: Martin, Gregory M., et al.
Publicado: (2023) -
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
por: Mallory, Katherine L., et al.
Publicado: (2021) -
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018) -
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023) -
Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)
por: Parums, Dinah V.
Publicado: (2021)